Coumarin–benzimidazole hybrids: synthesis, antioxidant potential and biological evaluation against antimicrobial agent

Vol. 1, 2019 - 112705
Poster only
Favorite this paper
How to cite this paper?
Abstract

Heterocyclic compounds have important biological activities. Coumarins have pharmacological properties, such as: anti-inflammatories, antibiotics, anticoagulants and are used in medicinal chemistry[1] . Others heterocycles, with Benzimidazoles have antioxidants, anti-inflammatories, antiviral properties[2]. Coumarin-benzimidazole hybrids[3] were synthesized using an ionic liquid (MAI.Cl) as catalyst to obtain compounds with pharmacological properties (30-41% yields). The product were confirmed (m.p, FTIR, NMR 1H and 13C). Antioxidant activity was determined as radical scavenging activity using 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. The absorbance with respect to control is calculated as antioxidant potential, probit regress was applied and EC50 (mol/L) values, due to the non-linear relationship of the method (EC50 15.5±71.5 mol/L and comparative gives literature). Benzothiazole, Benzoxazole, Coumarin–benzimidazole and Coumarin–benzothiazole were screened for their in vitro antibacterial activity against Staphylococcus aureus and Escherichia coli strains by microdilution method CLSI: 125 >2000 mg/mL were observed. In conclusion, were synthesized hybrids and evaluated them for their antibacterial activities and antioxidant potential.

Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
Heterocyclic
hybrids
Bioactivity